Cheniere Energy vs Koninklijke Philips NV — how do they compare? Cheniere Energy trades at $278.18 (market cap $57.39B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Cheniere Energy is far larger — about 2.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and Koninklijke Philips NV for 84 Days on average.
| LNG | PHG | |
|---|---|---|
Market Cap | $57.39B | $23.52B |
Volume | 1,215,835 | 1,635,069 |
Sector | Energy | Health |
52-Week High | $296.91 | $32.91 |
52-Week Low | $188.83 | $23.81 |
Typical Hold Time | 10 Days | 84 Days |
Enterprise Value | $82.85B | $29.87B |
Dividend Yield | 0.8% | 4.17% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite three consecutive quarterly earnings beats. The company shows improving fundamentals with net income turning positive at $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care.
While analyst consensus leans Hold (63.64%), the improving profitability trajectory and reasonable valuation (P/E 18.94) present opportunity, though technical weakness and competitive healthcare market risks require monitoring. The stock faces resistance near $25 with support at $24, with institutional ownership showing mixed signals through recent acquisitions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →